Back to results
US 2026/0092065 A1Published application
Crystalline solid forms of a bet inhibitor
AssigneeIncyte Corporation
InventorsShili Chen, Zhongjiang Jia, Pingli Liu, Lei Qiao, Yongzhong Wu, Jiacheng Zhou, Qun Li
Life of this patent
Estimating the term…
Abstract
The present application relates to crystalline solid forms of an inhibitor of BET proteins such as BRD2, BRD3, BRD4, and BRD-t, including methods of preparation thereof, and intermediates in the preparation thereof, where the compound is useful in the treatment of diseases such as cancer.
Claims42
1-23. (canceled)
A method of treating an autoimmune or inflammatory disease comprising administering to a patient in need of such treatment a therapeutically effective amount of a solid form of a compound having the formula:
- wherein the solid form is crystalline;
- and wherein the solid form is selected from Form Ia, Form III, Form IV, Form V, Form Va, Form VI, Form VII, Form VIII, Form IX, Form X, Form XI, Form XII, Form XIII, Form XIV, and Form XV.
26-53. (canceled)
Dependencies are inferred from the claim text.